Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Cervical Cancer

Free Subscription Articles published in Radiother Oncol Retrieve available abstracts of 28 articles: HTML format

Single Articles

March 2026
1. YANG XL, Zhu JW, Wang C, Zhou YC, et al
   Radiation- versus surgery-based treatment for patients with resectable IIIC1 cervical adenocarcinoma.
   Radiother Oncol. 2026;216:111370.
   PubMed     Abstract available
   
   
   February 2026
2. CORBEAU A, Spampinato S, Charnalia M, Ranjan N, et al
   Normal tissue complication probability models for gastrointestinal toxicity after adjuvant (chemo)radiotherapy for cervical cancer in the PARCER trial.
   Radiother Oncol. 2026;218:111444.
   PubMed     Abstract available
   
   
   January 2026
3. SPAMPINATO S, Kutluyer S, Almaz S, Schuur N, et al
   Impact of primary radiotherapy on the psychosocial well-being of patients with locally advanced cervical cancer (IMPRaCC study).
   Radiother Oncol. 2026 Jan 30:111405. doi: 10.1016/j.radonc.2026.111405.
   PubMed     Abstract available
   
   
   
4. GULSTENE S, Liu ZA, Milosevic M, Croke J, et al
   Pain control and opioid use as a function of workflow in MRI-guided interstitial cervix brachytherapy.
   Radiother Oncol. 2026;214:111239.
   PubMed     Abstract available
   
   
   
5. XU B, Liu J, Fang M, Zhu H, et al
   Multicenter deep learning-based automatic delineation of CTV and PTV in uterine malignancy CT imaging.
   Radiother Oncol. 2026;214:111212.
   PubMed     Abstract available
   
   
   November 2025
6. ZIMMERMANN L, Knausl B, Knoth J, Sturdza A, et al
   Diffusion weighted imaging for gross tumor volume delineation in primary radiochemotherapy and image guided adaptive brachytherapy for cervical cancer.
   Radiother Oncol. 2025;214:111306.
   PubMed     Abstract available
   
   
   October 2025
7. ROSSI L, Nout R, Heijmen B
   Response to letter to editor "Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit".
   Radiother Oncol. 2025 Oct 21:111217. doi: 10.1016/j.radonc.2025.111217.
   PubMed    
   
   
   
8. FANG S, Gao M
   Re-evaluating 'Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy': The silent cumulative CTVIR deficit.
   Radiother Oncol. 2025 Oct 19:111216. doi: 10.1016/j.radonc.2025.111216.
   PubMed    
   
   
   September 2025
9. SERBAN M, Spampinato S, de Leeuw A, Fortin I, et al
   Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis.
   Radiother Oncol. 2025;210:110954.
   PubMed     Abstract available
   
   
   August 2025
10. CORBEAU A, Astreinidou E, Kuipers SC, Wielopolski PA, et al
    Changes in bone marrow fat fraction and immune cell counts in women with cervical cancer treated with primary chemoradiotherapy.
    Radiother Oncol. 2025;211:111089.
    PubMed     Abstract available
    
    
    July 2025
11. ROSSI L, Bijman R, Westerveld H, Christianen M, et al
    Prospective evaluation of AI-based BiCycle autoplanning for advanced cervical cancer brachytherapy.
    Radiother Oncol. 2025;210:111029.
    PubMed     Abstract available
    
    
    March 2025
12. DE HOND YJM, van Haaren PMA, Verrijssen AE, Tijssen RHN, et al
    Dosimetric evaluation of variation in Library of plans selection for cervical cancer radiotherapy.
    Radiother Oncol. 2025;206:110835.
    PubMed     Abstract available
    
    
    
13. JAIN J, Serban M, Assenholt MS, Hande V, et al
    Can knowledge-based planning models validated on ethnically diverse patients lead to global standardisation of external beam radiation therapy for locally advanced cervix cancer?
    Radiother Oncol. 2025;204:110694.
    PubMed     Abstract available
    
    
    February 2025
14. GAO H, Wu H, Zhang Y, Wang S, et al
    Dose-volume constraints for severe acute gastrointestinal toxicity in cervical cancer patients receiving extended-field intensity-modulated radiotherapy and concurrent chemotherapy.
    Radiother Oncol. 2025 Feb 4:110777. doi: 10.1016/j.radonc.2025.110777.
    PubMed     Abstract available
    
    
    January 2025
15. LIU Y, Chen Z, Zhou Q, Shang X, et al
    A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose.
    Radiother Oncol. 2025;202:110593.
    PubMed     Abstract available
    
    
    December 2024
16. WU Z, Lu L, Xu C, Wang D, et al
    Development and external validation of a multi-task feature fusion network for CTV segmentation in cervical cancer radiotherapy.
    Radiother Oncol. 2024;204:110699.
    PubMed     Abstract available
    
    
    August 2024
17. NI R, Han K, Haibe-Kains B, Rink A, et al
    Generalizability of deep learning in organ-at-risk segmentation: A transfer learning study in cervical brachytherapy.
    Radiother Oncol. 2024;197:110332.
    PubMed     Abstract available
    
    
    July 2024
18. MARSILLA J, Weiss J, Ye XY, Welch M, et al
    A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study.
    Radiother Oncol. 2024;199:110463.
    PubMed     Abstract available
    
    
    May 2024
19. AI Y, Zhu X, Zhang Y, Li W, et al
    MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Radiother Oncol. 2024;197:110328.
    PubMed     Abstract available
    
    
    March 2024
20. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    PubMed     Abstract available
    
    
    
21. KUIPERS SC, Godart J, Corbeau A, Breedveld S, et al
    Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 10:110222. doi: 10.1016/j.radonc.2024.110222.
    PubMed     Abstract available
    
    
    
22. HUI C, Ewongwo A, Mendoza MG, Kozak MM, et al
    Less than whole uterus irradiation for patients with locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 2:110199. doi: 10.1016/j.radonc.2024.110199.
    PubMed     Abstract available
    
    
    November 2023
23. REIJTENBAGH D, Godart J, Penninkhof J, Quint S, et al
    Nine years of plan of the day for cervical cancer: Plan library remains effective compared to fully online-adaptive techniques.
    Radiother Oncol. 2023;190:110009.
    PubMed     Abstract available
    
    
    September 2023
24. NOUT R, Calaminus G, Planchamp F, Chargari C, et al
    ESTRO/ESGO/SIOPe guidelines for the management of patients with vaginal cancer.
    Radiother Oncol. 2023;186:109662.
    PubMed     Abstract available
    
    
    July 2023
25. CIBULA D, Rosaria Raspollini M, Planchamp F, Centeno C, et al
    ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023.
    Radiother Oncol. 2023;184:109682.
    PubMed     Abstract available
    
    
    June 2023
26. ECKER S, Kirisits C, Schmid M, Knoth J, et al
    EviGUIDE - A tool for evidence-based decision making in image-guided adaptive brachytherapy for cervical cancer.
    Radiother Oncol. 2023 Jun 15:109748. doi: 10.1016/j.radonc.2023.109748.
    PubMed     Abstract available
    
    
    
27. CHARGARI C, Tanderup K, Planchamp F, Chiva L, et al
    ESGO/ESTRO quality indicators for radiation therapy of cervical cancer.
    Radiother Oncol. 2023;183:109589.
    PubMed     Abstract available
    
    
    March 2023
28. OKAMOTO H, Murakami N, Isohashi F, Kasamatsu T, et al
    Plan quality association between dummy run and individual case review in a prospective multi-institutional clinical trial of postoperative cervical cancer patients treated with intensity-modulated radiotherapy: Japan Clinical Oncology Group study (JCO
    Radiother Oncol. 2023 Mar 17:109630. doi: 10.1016/j.radonc.2023.109630.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cervical Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum